Valuation: Vitrolife AB

Market Cap 11.54B 1.19B 1.04B 972M 892M 1.68B 115B 1.7B 4.51B 56.32B 4.47B 4.37B 195B P/E 2026 *
23.4x
P/E 2027 * 18.9x
Enterprise Value 12.09B 1.25B 1.09B 1.02B 934M 1.75B 120B 1.78B 4.72B 59B 4.68B 4.58B 204B EV / Sales 2026 *
3.5x
EV / Sales 2027 * 3.11x
Free-Float
54.39%
Yield 2026 *
1.3%
Yield 2027 * 1.48%
1 day-0.41%
1 week-7.69%
Current month-2.91%
1 month-4.96%
3 months-26.55%
6 months-30.34%
Current year-37.81%
1 week 84.9
Extreme 84.9
89.95
1 month 84.85
Extreme 84.85
101.9
Current year 84.6
Extreme 84.6
139.6
1 year 84.6
Extreme 84.6
153.5
3 years 84.6
Extreme 84.6
268
5 years 84.6
Extreme 84.6
585
10 years 70
Extreme 70
585
Manager TitleAgeSince
Chief Executive Officer 52 01/08/2023
Director of Finance/CFO 55 10/10/2025
Chief Investment Officer 39 -
Director TitleAgeSince
Director/Board Member 63 19/04/2013
Chairman 70 01/08/2023
Chairman 55 -
Date Insider Type Main position Quantity % Market Cap.
06/02/26 Buy

Chief Operating Officer

6,470 0.0048%
06/02/26 Buy

Chief Executive Officer

3,013 0.0022%
04/02/26 Buy

Chief Financial Officer

2,200 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
-0.41%-7.69%-42.47%-49.16% 1.19B
-1.91%-5.48%+231.67%+282.68% 19.54B
+1.30%-4.25%-44.21%-27.44% 9.39B
+1.05%-2.57%+43.73%+24.68% 6.82B
-3.72%+5.78%+227.92%-23.82% 5.87B
+1.38%+7.00%-15.41%-21.37% 5.61B
-0.83%-5.88%-47.46% - 4.39B
-8.03%-14.67%+71.70%+90.15% 4.19B
0.00%-3.72%-26.25%-30.45% 4.03B
-2.24%-2.39%-21.94%-45.08% 2.66B
Average -1.34%-3.07%+37.73%+22.24% 6.37B
Weighted average by Cap. -1.19%-3.13%+86.99%+88.55%

Financials

2026 *2027 *
Net sales 3.46B 356M 313M 291M 267M 502M 34.33B 510M 1.35B 16.88B 1.34B 1.31B 58.35B 3.71B 382M 336M 312M 286M 538M 36.81B 547M 1.45B 18.1B 1.43B 1.4B 62.57B
Net income 493M 50.78M 44.6M 41.48M 38.06M 71.51M 4.89B 72.61M 192M 2.4B 191M 187M 8.31B 609M 62.76M 55.12M 51.26M 47.04M 88.39M 6.04B 89.75M 238M 2.97B 236M 231M 10.27B
Net Debt 549M 56.61M 49.72M 46.24M 42.43M 79.72M 5.45B 80.95M 215M 2.68B 213M 208M 9.27B -26.74M -2.76M -2.42M -2.25M -2.07M -3.88M -265M -3.94M -10.45M -131M -10.35M -10.13M -451M
Logo Vitrolife AB
Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.
Employees
1,103
Date Price Change Volume
24/07/26 SEK 85.20 -0.41% 89,601
23/07/26 SEK 85.55 -3.22% 174,313
22/07/26 SEK 88.40 -0.28% 213,365
21/07/26 SEK 88.65 -1.39% 238,969
20/07/26 SEK 89.90 -2.60% 136,103
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
85.20SEK
Average target price
129.60SEK
Spread / Average Target
+52.11%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VITR Stock